Brandon Fenn represents venture capital funds and technology, biotechnology, medical device and other high-growth companies. His practice includes mergers and acquisitions, venture capital financings, public offerings and general corporate counseling.

Download full bio 

Experience

  • NerdWallet – $150.1 Million IPO 

  • Molecular Partners – $64 Million IPO 

  • VectivBio – $147 Milion IPO 

  • Edgewise Therapeutics – $202 Million IPO 

  • DigitalOcean $776 Million IPO 

  • View all

Education

  • New York University School of Law
    JD, 2010

  • Dartmouth College
    BA, 2007


Admissions & Credentials

Minnesota

New York